A second, and perhaps more likely, explanation for the reduced expression/shedding of PDGFRβ in COVID-19 patients is that SARS-CoV-2 infection of pericytes diverted the protein synthesis machinery to produce viral proteins, leading to loss of endogenous marker expression [31] and consequential functional impairment. This evidence concerns the gene PDGFRB and COVID-19.